(2S,3R)-2-((3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl)methylamino)octadec-5-ene-1,3-diol

ID: ALA486485

Chembl Id: CHEMBL486485

PubChem CID: 44583047

Max Phase: Preclinical

Molecular Formula: C26H46N2O4

Molecular Weight: 450.66

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCC/C=C/C[C@@H](O)[C@H](CO)NCc1c(CO)cnc(C)c1O

Standard InChI:  InChI=1S/C26H46N2O4/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-25(31)24(20-30)28-18-23-22(19-29)17-27-21(2)26(23)32/h14-15,17,24-25,28-32H,3-13,16,18-20H2,1-2H3/b15-14+/t24-,25+/m0/s1

Standard InChI Key:  DVXZNLNDQNAWRX-HGMGIVORSA-N

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Sgpl1 Sphingosine-1-phosphate lyase 1 (3 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 450.66Molecular Weight (Monoisotopic): 450.3458AlogP: 4.66#Rotatable Bonds: 19
Polar Surface Area: 105.84Molecular Species: BASEHBA: 6HBD: 5
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 8.09CX Basic pKa: 8.61CX LogP: 3.74CX LogD: 3.35
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.16Np Likeness Score: 0.94

References

1. Bagdanoff JT, Donoviel MS, Nouraldeen A, Tarver J, Fu Q, Carlsen M, Jessop TC, Zhang H, Hazelwood J, Nguyen H, Baugh SD, Gardyan M, Terranova KM, Barbosa J, Yan J, Bednarz M, Layek S, Courtney LF, Taylor J, Digeorge-Foushee AM, Gopinathan S, Bruce D, Smith T, Moran L, O'Neill E, Kramer J, Lai Z, Kimball SD, Liu Q, Sun W, Yu S, Swaffield J, Wilson A, Main A, Carson KG, Oravecz T, Augeri DJ..  (2009)  Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.,  52  (13): [PMID:19489538] [10.1021/jm900278w]

Source